Looks to be some profit taking - not surprising after the highest closing price in over a year and a half. I am sure some of those that bought into the $4.25 offering, and other offerings at even lower levels, are taking some off the table. Glad the stock is holding up and only going down to levels of the day before yesterday. Low basis shareholders being replaced with higher basis shareholders. We may actually end the day in plus territory. Either way, the volume levels are great, removing some of the upper resistance levels. JMHO.
Pretty big sell off today, and could be a little manipulation involved also. However stock has made a big run the past month. The sooner Ampion data is out, the better. Those results, and Optina's, will determine the future of Ampio. In regards to Ampion, with Orthopods now recommending neither Synvisc nor Steroids, the bar is set pretty low for Ampion to show superior efficacy.